Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cost of Revenue (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Cost of Revenue data on record, last reported at $3.1 million in Q4 2012.

  • For Q4 2012, Cost of Revenue rose 1639.78% year-over-year to $3.1 million; the TTM value through Dec 2012 reached $2.3 million, down 25.87%, while the annual FY2012 figure was $776000.0, 78.52% down from the prior year.
  • Cost of Revenue reached $3.1 million in Q4 2012 per SNOA's latest filing, up from $234000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $3.1 million in Q4 2012 and bottomed at -$1.3 million in Q1 2012.
  • Average Cost of Revenue over 3 years is $722818.2, with a median of $885000.0 recorded in 2011.
  • The widest YoY moves for Cost of Revenue: up 1639.78% in 2012, down 225.59% in 2012.
  • A 3-year view of Cost of Revenue shows it stood at $925000.0 in 2010, then tumbled by 80.43% to $181000.0 in 2011, then surged by 1639.78% to $3.1 million in 2012.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $3.1 million in Q4 2012, $234000.0 in Q3 2012, and $179000.0 in Q2 2012.